Compound information
- Natural Products
- ZC2136358
- Molecular Formula
- C18H18N4OS
- Molecular Weight
- 338.120132196 g/mol
- Structure
-
- IUPAC Name
- 4-(1,3-benzothiazol-2-yl)-N-phenyl-piperazine-1-carboxamide
- InChI
- InChI=1S/C18H18N4OS/c23-17(19-14-6-2-1-3-7-14)21-10-12-22(13-11-21)18-20-15-8-4-5-9-16(15)24-18/h1-9H,10-13H2,(H,19,23)
- InChI Key
- ZPSAXOLPNUDKFO-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccccc1)N1CCN(c2nc3ccccc3s2)CC1
- Source
- ZINC000000462877
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 4 |
Heteroatom Count | 6 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 3.784 |
LogS | -5.173 | LogD | 3.826 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.096 | Pgp substrate | 0.212 |
HIA | 0.965 | F20 % | 0.994 |
F30 % | 0.955 | Caco-2 | -4.579 |
MDCK | -4.932 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.049 | PPB | 98.501 |
VD | 1.152 | Fu | 1.705 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.996 | CYP1A2 substrate | 0.789 |
CYP2A6 substrate | 0.501 | CYP2B6 substrate | 0.659 |
CYP2C19 inhibitor | 0.955 | CYP2C19 substrate | 0.721 |
CYP2C8 substrate | 0.74 | CYP2C9 inhibitor | 0.859 |
CYP2C9 substrate | 0.611 | CYP2D6 inhibitor | 0.186 |
CYP2D6 substrate | 0.97 | CYP2E1 substrate | 0.815 |
CYP3A4 inhibitor | 0.103 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.688 | CL | 3.227 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.818 | Hepatotoxicity | 0.547 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.242 |
FDAMDD | 0.291 | Skin Sensitization | 0.958 |
Carcinogenicity | 0.985 | Eye Corrosion | 0.002 |
Eye Irritation | 0.01 | Respiratory Toxicity | 0.895 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.278 | IGC50 | 3.515 |
LC50FM | 0.278 | LC50DM | -6.363 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.706 | NR-AR-LBD | 0.313 |
NR-AhR | 0.969 | NR-Aromatase | 0.032 |
NR-ER | 0.752 | NR-ER-LBD | 0.385 |
NR-PPAR-gamma | 0.667 | SR-ARE | 0.899 |
SR-ATAD5 | 0.849 | SR-HSE | 0.174 |
SR-MMP | 0.847 | SR-p53 | 0.82 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.